Commercialization of precision diagnostics/companion diagnostics
We offer a flexible model for support of precision diagnostic that can be modulated to fit the different markets needs for support.
When developing new precision diagnostic tests, the Dx/Rx partnership is a well established paradigm. We propose the addition of the Lx, the laboratory CRO.
What we offer
- A rich toolbox of CDx-relevant technology
- An exceptional menu of services supporting clinical trials, diagnostic development and commercialisation
- Intimate knowledge of local testing standards and regulatory requirements
- Speed and efficiency in method development and transfer
- Competence in navigating logistical challenges throughout Europe and North America
- With more than 250 laboratories in 13 European countries we can support market access of both central and localized testing of new precision diagnostic tests into European market.